Immune Design to Present at Upcoming Investor Conferences

Friday, February 10, 2017 1:00 PM UTC

SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 10, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that Carlos Paya, M.D., Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences.

Leerink Partners Global Healthcare Conference
Thursday, February 16, 2017 at 10:30 a.m. Eastern Time in New York.

Cowen and Company 37th Annual Health Care Conference
Wednesday, March 8, 2017 at 8:40 a.m. Eastern Time in Boston.

A live webcast of each presentation will be available online from the investor relations page of the company's corporate website at http://ir.immunedesign.com/events.cfm. After the live webcast, an archive of each presentation will be available on the company website for 30 days.

About Immune Design

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body's immune system to fight disease. The company's technologies are engineered to activate the immune system's natural ability to generate and/or expand antigen-specific cytotoxic T cells, while also enhancing other immune effectors, to fight cancer and other chronic diseases. CMB305 and G100, the primary focus of Immune Design's ongoing immuno-oncology clinical programs, are products of its two synergistic discovery platforms, ZVex® and GLAAS^TM. Immune Design has offices in Seattle and South San Francisco. For more information, visit www.immunedesign.com.

Media Contact
Julie Rathbun
Rathbun Communications
[email protected]                   
206-769-9219

Investor Contact
Shari Annes
Annes Associates
[email protected]
650-888-0902

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Immune Design to Present at Upcoming Investor Conferences

Editor's Picks

Welcome to EconoTimes